Is syrup of ipecac still for sale? Comparison of pharmacies in a large urban area - 2003 Versus 2005

Clinical Pediatrics

Volumn 46, Issue 4, 2007, Pages 320-324

  Kelly, Nancy R ^a,c   Sanchez, Sarai H ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Pharmacies; Poisoning; Syrup of ipecac

Indexed keywords

IPECAC;

DRUG CONTRAINDICATION; DRUG MARKETING; INTERVIEW; MEDICAL SOCIETY; PEDIATRICS; PHARMACY; REVIEW; STATISTICAL SIGNIFICANCE; TELEPHONE; UNITED STATES; URBAN AREA;

ACADEMIES AND INSTITUTES; DRUG UTILIZATION; EMETICS; HEALTH SERVICES ACCESSIBILITY; HUMANS; IPECAC; PHARMACIES; POISONING; TEXAS; TIME FACTORS; URBAN POPULATION;

EID: 34247223740     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922806294069     Document Type: Review

References (42)

1. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: ipecac syrup. J Toxicol Clin Toxicol. 1997 ; 35: 699-709.
2. Ipecac syrup. Vol. OTC 21 CFR 201.308; 1965.
3. Schiff RJ, Wurzel CL, Brunson SC, Kasloff I., Nussbaum MP, Frank SD Death due to chronic ipecac use in a patient with bulimia. Pediatrics. 1986 ; 78: 412-416.
4. McClung HJ, Murray R., Braden NJ, Fyda J., Myers RP, Gutches L. Intentional ipecac poisoning in children. Am J Dis Child. 1988 ; 142: 637-639.
5. Bond GR Home syrup of ipecac use does not reduce emergency department use or improve outcome. Pediatrics. 2003 ; 112: 1061-1064.
6. Watson WA, Litovitz TL, Rodgers GC, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2005 ; 23: 589-666.
7. Krenzelok EP Ipecac syrup-induced emesis... no evidence of benefit. Clin Toxicol (Phila). 2005 ; 1: 11-12.
8. Adler AG, Walinsky P., Krall RA, Cho SY Death resulting from ipecac syrup poisoning. JAMA. 1980 ; 243: 1927-1928.
9. Brotman MC, Forbath N., Garfinkel PE, Humphrey JG Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa. Can Med Assoc J. 1981 ; 125: 453-454.
10. Bennett HS, Spiro AJ, Pollack MA, Zucker P. Ipecac-induced myopathy simulating dermatomyositis. Neurology. 1982 ; 32: 91.
11. Friedman EJ Death from ipecac intoxication in a patient with anorexia nervosa. Am J Psychiatry. 1984 ; 141: 702-703.
12. Mateer JE, Farrell BJ, Chou SS, Gutmann L. Reversible ipecac myopathy. Arch Neurol. 1985 ; 42: 188-189.
13. Moldawsky RJ Myopathy and ipecac abuse in a bulimic patient. Psychosomatics. 1985 ; 26: 448-449.
14. Palmer EP, Guay AT Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med. 1985 ; 313: 1457-1459.
15. Dawson JA, Yager J. A case of abuse of syrup of ipecac resulting in death. J Am Coll Health. 1986 ; 34: 280-282.
16. Rosenberg NL, Ringel SP Myopathy from surreptitious ipecac ingestion. West J Med. 1986 Sept; 145: 386-388.
17. Friedman AG, Seime RJ, Roberts T., Fremouw WJ Ipecac abuse: a serious complication in bulimia. Gen Hosp Psychiatry. 1987 ; 9: 225-228.
18. Kuntzer T., Bogousslavsky J., Deruaz JP, Janzer R., Regli F. Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy. J Neurol. 1989 ; 236: 246-248.
19. Dresser LP, Massey EW, Johnson EE, Bossen E. Ipecac myopathy and cardiomyopathy. J Neurol Neurosurg Psychiatry. 1993 ; 56: 560-562.
20. Thyagarajan D., Day BJ, Wodak J., Gilligan B., Dennett X. Emetine myopathy in a patient with an eating disorder. Med J Aust. 1993 ; 159: 757-760.
21. Ho PC, Dweik R., Cohen MC Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clin Cardiol. 1998 ; 21: 780-783.
22. Manno BR, Manno JE Toxicology of ipecac: a review. Clin Toxicol. 1977 ; 10: 221-242.
23. McClung HJ, Murray R., Braden NJ, Fyda J., Myers RP, Gutches L. Intentional ipecac poisoning in children. Am J Dis Child. 1988 ; 142: 637-639.
24. Berkner P., Kastner T., Skolnick L. Chronic ipecac poisoning in infancy: a case report. Pediatrics. 1988 ; 82: 384-386.
25. Sutphen JL, Saulsbury FT Intentional ipecac poisoning: Munchausen syndrome by proxy. Pediatrics. 1988 ; 82: 453-456.
26. Colletti RB, Wasserman RC Recurrent infantile vomiting due to intentional ipecac poisoning. J Pediatr Gastroenterol Nutr. 1989 ; 8: 394-396.
27. Day L., Kelly C., Reed G. Andersen JM, Keljo JM Fatal cardiomyopathy: suspected child abuse by chronic ipecac administration. Vet Hum Toxicol. 1989 ; 31: 255-257.
28. Santangelo WC, Richey JE, Rivera L., Fordtran JS Surreptitious ipecac administration simulating intestinal pseudo-obstruction. Ann Intern Med. 1989 ; 110: 1031-1032.
29. Johnson JE, Carpenter BL, Benton J., Cross R., Eaton LA Jr, Rhoads JM Hemorrhagic colitis and pseudomelanosis coli in ipecac ingestion by proxy. J Pediatr Gastroenterol Nutr. 1991 ; 12: 501-506.
30. Goebel J., Gremse DA, Artman M. Cardiomyopathy from ipecac administration in Munchausen syndrome by proxy. Pediatrics. 1993 ; 92: 601-603.
31. Schneider DJ, Perez A., Knilamus TE, Daniels SR, Bove KE, Bonnell H. Clinical and pathologic aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy. Pediatrics. 1996 ; 97: 902-906.
32. Dershewitz RA, Niederman LG Ipecac at home - a health hazard? Clin Toxicol. 1981 ; 18: 969-972.
33. Mofenson HC, Caraccio TR Benefits/risks of syrup of ipecac. Pediatrics. 1986 ; 77: 551-552.
34. Shannon M. The demise of ipecac (commentary) Pediatrics. 2003 ; 112: 1180-1181.
35. American Academy of Pediatrics, Committee on Injury, Violence, and Poison Prevention. Poison treatment in the home. Pediatrics. 2003 ; 112: 1182-1185.
36. Manoguerra AS, Cobaugh DJ, Guidelines for the Management of Poisoning Consensus Panel. Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons. Clin Toxical (Phila). 2005 ; 1: 1-10.
37. Pope HG, Hudson JI, Nixon RA, Herridge PL The epidemiology of ipecac abuse. New Engl J Med. 1986 ; 314: 245-246.
38. Humphries LL, Shirley PB, Piascik MT Ipecac misuse in clinical and non-clinical samples. Int J Eat Disord. 1992 ; 11: 361-367.
39. Greenfeld D., Mickley D. Quinlan DM, Roloff P. Ipecac abuse in a sample of eating disordered outpatients. Int J Eat Disord. 1993 ; 13: 411-414.
40. Silber TJ Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status? J Adolesc Health. 2005 ; 37: 256-260.
41. Brushwood DB, Tietze KJ Regulatory controversy surrounding ipecac use and misuse. Am J Hosp Pharm. 1986 ; 43: 157-161.
42. Morgan DL, Forrester MB Texas poisonings at the beginning of the 21st century: 2000 through 2002. Texas Med. 2005 ; 101: 72-78.